SEM - Select Medical Holdings Corporation
22.79 +0.02 (0.09%)
After hours: 6:45PM EST
| Previous Close | 22.81 |
| Open | 22.75 |
| Bid | 22.84 x 900 |
| Ask | 22.85 x 900 |
| Day's Range | 22.67 - 23.00 |
| 52 Week Range | 12.96 - 23.50 |
| Volume | 602,412 |
| Avg. Volume | 563,245 |
| Market Cap | 3B |
| Beta (5Y Monthly) | 1.27 |
| PE Ratio (TTM) | 21.89 |
| EPS (TTM) | 1.04 |
| Earnings Date | Feb 19, 2020 - Feb 24, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 2015-03-02 |
| 1y Target Est | 23.57 |
- Simply Wall St.
What Is Select Medical Holdings Corporation's (NYSE:SEM) Share Price Doing?
Select Medical Holdings Corporation (NYSE:SEM), which is in the healthcare business, and is based in United States...
- Zacks
Humana's (HUM) Alliances to Offer Relief to Members With CKD
Humana (HUM) collaborates with Monogram Health and Somatus to provide its Humana Medicare Advantage and Commercial members, who are renal patients, with better healthcare in select geographies.
- Zacks
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
Riding high on a growing top line and higher membership, Anthem (ANTM) holds enough potential to reap benefits for investors.
- PR Newswire
Select Medical Corporation Closes Private Placement of $675 Million of 6.250% Senior Notes due 2026
Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") has completed its private placement of $675 million aggregate principal amount of its 6.250% Senior Notes due 2026 as additional notes (the "Additional Notes") under same indenture as Select's existing $550 million aggregate principal amount of 6.250% senior notes due 2026 that were originally issued on August 1, 2019 and, as such, will form a single series and trade interchangeably with such previously issued notes.
- PR Newswire
Select Medical Corporation Announces Pricing and Upsizing of its Offering of an Additional $675 million of its 6.250% Senior Notes due 2026
Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") has priced its private placement of $675 million aggregate principal amount of its 6.250% senior notes due 2026 (the "Additional Notes") as additional notes under the indenture pursuant to which it previously issued $550 million of 6.250% senior notes due 2026. The offering has been upsized from the previously announced amount of $625 million. The offering is expected to close on December 10, 2019, subject to the satisfaction of customary closing conditions.
- PR Newswire
Select Medical Corporation Announces Proposal to Commence Offering $625 Million of Senior Notes
Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") proposes to commence an offering through a private placement, subject to market and other conditions, of $625 million aggregate principal amount of 6.250% senior notes due 2026. It is anticipated that the notes will be issued as additional notes under the same indenture as Select's existing $550 million aggregate principal amount of 6.250% senior notes due 2026 that were originally issued on August 1, 2019 and, as such, will form a single series and trade interchangeably with such previously issued notes. The notes will be senior unsecured obligations of Select and will be guaranteed by certain of Select's subsidiaries.
- Zacks
Here's Why Select Medical (SEM) Stock Looks Attractive
Select Medical (SEM) benefits from revenue growth, acquisitions, and strong earnings guidance.
- Zacks
Ensign Group (ENSG) on Buyout Binge to Boost Capabilities
Ensign Group's (ENSG) acquisition spree in Texas and Arizona will enhance its portfolio and better serve the local communities.
- Zacks
Here's Why Should You Hold MEDNAX (MD) in Your Portfolio
Riding high on its solid top line as well as strategic buyouts, MEDNAX (MD) holds enough potential to generate returns for investors.
- Zacks
Centene (CNC) Divests IlliniCare as Part of Merger Agreement
Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.
- Zacks
Are Investors Undervaluing Select Medical (SEM) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Moody's
Select Medical Holdings Corporation -- Moody's affirms Select Medical's B1 CFR; outlook stable
Moody's Investors Service ("Moody's") today affirmed the existing ratings of Select Medical Holdings Corporation ("Select"), including the B1 Corporate Family Rating and B1-PD Probability of Default Rating. Moody's also affirmed the ratings of Select Medical Corporation (a wholly owned subsidiary of Select Medical Holdings Corporation), including the Ba2 senior secured rating and B3 unsecured rating. The rating agency also affirmed the Ba2 rating on Select's newly upsized term loan.
- Zacks
Magellan Health's PBM Division Unveils Care Management Plan
Magellan Health's (MGLN) pharmacy benefit management division's newly-launched plan is expected to drive value-added healthcare.
- Zacks
Humana, Epione Tie Up to Aid Medicare Advantage Members
Humana (HUM) inks deal with Epione Health of Oklahoma to provide better patient care.
- Zacks
UnitedHealth Group to Enhance its Medicare Advantage Network
UnitedHealth Group (UNH) partners Walgreens to provide better access to MA members.
- Zacks
Why is HCA Healthcare an Attractive Stock for Your Portfolio?
Growing revenues and a strong capital position bode well for HCA Healthcare (HCA).
- Zacks
The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical
The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical
- Zacks
Why Should You Hold Universal Health in Your Portfolio?
Banking on its growing top line and strong segments, Universal Health (UHS) holds potential to reap benefits for investors.
- Thomson Reuters StreetEvents
Edited Transcript of SEM earnings conference call or presentation 1-Nov-19 1:00pm GMT
Q3 2019 Select Medical Holdings Corp Earnings Call
- Zacks
Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD
Healthcare bounced back with an outperformance starting the fourth quarter.
- Zacks
Humana (HUM) to Boost Medicare Advantage Network in Hawaii
Humana (HUM) teams up with Hawaii Senior Medical Group to enrich patient experience of Medicare Advantage members in the region.
- Simply Wall St.
How Should Investors React To Select Medical Holdings Corporation's (NYSE:SEM) CEO Pay?
In 2014 David Chernow was appointed CEO of Select Medical Holdings Corporation (NYSE:SEM). This report will, first...
- Zacks
Humana (HUM) Scales New 52-Week High on Solid Q3 Earnings
Humana (HUM) reaches a 52-week high, backed by strong-third-quarter results and Medicare business.
